Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcin Miszczyk

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Journal of Contemporary Brachytherapy|March 2, 2022
Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancerMarcin Miszczyk, Łukasz Magrowski, Oliwia Masri, et al.
Urology|January 21, 2026
Automated Classification of Adverse Events After Hydrogel Perirectal Spacer Insertion for Prostate Cancer Using Large Language ModelsNishan Sohoni, Nimit S Sohoni, Ryan A Sutherland, et al.
Cancers|April 12, 2022
The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate CancerMarcin Miszczyk, Justyna Rembak-Szynkiewicz, Łukasz Magrowski, et al.
European Urology Focus|May 16, 2025
Prostate-specific Antigen Response as a Prognostic Factor for Overall Survival in Patients with Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Systematic Review and Meta-analysisMarcin Miszczyk, Tamás Fazekas, Paweł Rajwa, et al.
Physics and Imaging in Radiation Oncology|June 24, 2024
Dose-volume metric-based prediction of radiotherapy-induced lymphocyte loss in patients with non-small-cell lung cancer treated with modern radiotherapy techniquesZuzanna Nowicka, Kasper Kuna, Mateusz Łaszczych, et al.
Virchows Archiv : an International Journal of Pathology|July 6, 2026
Keratins and desmosomal proteins: Utility for molecular subtype identification in muscle-invasive bladder cancerAnna Katrin Scherping, Bartłomiej Tomasik, Jeton Luzha, et al.
Central European Journal of Urology|March 21, 2025
Role of PARP inhibitors in prostate cancerJulia Szczotka, Gabriela Szpila, Michał Hejduk, et al.
Healthcare (Basel, Switzerland)|July 26, 2024
Lower Urinary Tract Symptoms Correlate with Erectile Dysfunction and Premature Ejaculation but Not with Men's Sexual Activity: Results from a Large Population-Representative StudyMikolaj Przydacz, Pawel Rajwa, Sabrina De Cillis, et al.
European Urology Focus|November 22, 2024
Trimodality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Matched Cohort StudiesAkihiro Matsukawa, Takafumi Yanagisawa, Marcin Miszczyk, et al.
Biomedicines|October 27, 2022
Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological RiskMarcin Miszczyk, Monika Szołtysik, Maja Hasterok, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Journal of Contemporary Brachytherapy|March 2, 2022
Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancerMarcin Miszczyk, Łukasz Magrowski, Oliwia Masri, et al.
Urology|January 21, 2026
Automated Classification of Adverse Events After Hydrogel Perirectal Spacer Insertion for Prostate Cancer Using Large Language ModelsNishan Sohoni, Nimit S Sohoni, Ryan A Sutherland, et al.
Cancers|April 12, 2022
The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate CancerMarcin Miszczyk, Justyna Rembak-Szynkiewicz, Łukasz Magrowski, et al.
European Urology Focus|May 16, 2025
Prostate-specific Antigen Response as a Prognostic Factor for Overall Survival in Patients with Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Systematic Review and Meta-analysisMarcin Miszczyk, Tamás Fazekas, Paweł Rajwa, et al.
Physics and Imaging in Radiation Oncology|June 24, 2024
Dose-volume metric-based prediction of radiotherapy-induced lymphocyte loss in patients with non-small-cell lung cancer treated with modern radiotherapy techniquesZuzanna Nowicka, Kasper Kuna, Mateusz Łaszczych, et al.
Virchows Archiv : an International Journal of Pathology|July 6, 2026
Keratins and desmosomal proteins: Utility for molecular subtype identification in muscle-invasive bladder cancerAnna Katrin Scherping, Bartłomiej Tomasik, Jeton Luzha, et al.
Central European Journal of Urology|March 21, 2025
Role of PARP inhibitors in prostate cancerJulia Szczotka, Gabriela Szpila, Michał Hejduk, et al.
Healthcare (Basel, Switzerland)|July 26, 2024
Lower Urinary Tract Symptoms Correlate with Erectile Dysfunction and Premature Ejaculation but Not with Men's Sexual Activity: Results from a Large Population-Representative StudyMikolaj Przydacz, Pawel Rajwa, Sabrina De Cillis, et al.
European Urology Focus|November 22, 2024
Trimodality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Matched Cohort StudiesAkihiro Matsukawa, Takafumi Yanagisawa, Marcin Miszczyk, et al.
Biomedicines|October 27, 2022
Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological RiskMarcin Miszczyk, Monika Szołtysik, Maja Hasterok, et al.
Pageof 14